Hôpital d'Enfants Béchir Hamza
Bab Saadoun, Tunis Governorate, 1029, Tunisia
NCT Number: NCT03105739
The purpose of this prospective, randomized study was to compare the incidence of adverse events associated with removal of the LMA either in deeply anesthetised or awake patients.
Looking for future studies?
Notify Me1 year–15 year
All sexes
Interventional
Not applicable
Bab Saadoun, Tunis Governorate, 1029, Tunisia
Written informed consent was obtained from parents for this prospective, randomized study conducted on children scheduled for minor surgery. Anesthesia was induced with sevoflurane, supplemented with propofol (3mg/kg) then maintained with nitrous oxide and sevoflurane 2-4% in oxygen. Analgesia was insured by peripheral nerve blocks. Included children were randomized into 2 groups:
Respiratory complications that occurred during LMA removal until 20 minutes afterwards were recorded. Children with respiratory history and those for whom peripheral nerve blocks failed, were excluded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
According to randomization, LMA device was removed at the end of surgery, either in deeply anesthetised patients or after consciousness recovery.
Time frame: from LMA removal to 20 minutes afterwards
Hôpital d'enfants Béchir-Hamza
Other
Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children: Early or Late Removal?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05068622
Digestive System Diseases, Gastric Outlet Obstruction
Amiens, France
View Trial DetailsNCT06521346
Cardiac Disease, Cardiovascular Diseases
Damanhūr, Egypt
View Trial DetailsNCT06502002
Acute Lung Injury, Lung Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial Details